Prospective Evaluation of Decision and Compliance With Antimalarials in Patients With Systemic Lupus

Prospective Evaluation of Adherence to Antimalarials in Patients With Systemic Lupus and Role of Therapeutic Education

This study is a biomedical, open label, therapeutic strategy, interventional, non-randomized, multicenter study to evaluate the non compliance to antimalarials in patients with systemic lupus in the Nord Pas-de-Calais region (FRANCE). It is conducted in two visits. These visits consist in obtaining blood sample, performing a clinical examination and filling in a questionnaire (Quality Of Life, Coping...).

The goal for the noncompliants patients is to guide them towards the therapeutic education with professionals (nurses and physicians).

Inclusion Criteria:

• patients with a systemic lupus with ACR criteria (at least 4 criterias)
• patients with antimalarials for at least 3 months with a minimum dose of 200 mg/day.

Exclusion Criteria:

• patients who refuse to sign the informed consent
• patients who are under guardianship